TARDBP and amyotrophic lateral sclerosis: Further research is crucial to understand the driving forces and consequences of TDP-43 phosphorylation and to identify therapeutic targets that can effectively regulate TDP-43 pathology while minimizing off-target effects, ultimately improving neuronal health in ALS and FTLD-TDP.